Home/Filings/4/0000950170-25-078982
4//SEC Filing

FitzPatrick Margaret M 4

Accession 0000950170-25-078982

CIK 0001880438other

Filed

May 28, 8:00 PM ET

Accepted

May 29, 4:17 PM ET

Size

4.9 KB

Accession

0000950170-25-078982

Insider Transaction Report

Form 4
Period: 2025-05-28
Transactions
  • Purchase

    Common Stock

    2025-05-28$1.18/sh+8,610$10,1338,610 total
Footnotes (1)
  • [F1]This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.17 to $1.18 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.

Documents

1 file

Issuer

AN2 Therapeutics, Inc.

CIK 0001880438

Entity typeother

Related Parties

1
  • filerCIK 0001873879

Filing Metadata

Form type
4
Filed
May 28, 8:00 PM ET
Accepted
May 29, 4:17 PM ET
Size
4.9 KB